Connection

Matteo Bassetti to Interleukin 1 Receptor Antagonist Protein

Back to Details
This is a "connection" page, showing publications Matteo Bassetti has written about Interleukin 1 Receptor Antagonist Protein.
Matteo Bassetti
Connection Strength
0.124
Interleukin 1 Receptor Antagonist Protein
  1. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.